Rising Dementia Rates are a Global Health Trend A positive aspect of rising living standards in most of the world has been a significant improvement in worldwide average life expectancies, increasing from 52 years in 1960 to 69 years in 2009. Regional differences are even more striking — the average life expectancy for a person [...]

After the disaster known as bapineuzumab Phase III, I think it’s time to seriously question whether clearing amyloid beta deposits from the brain has any therapeutic benefit to Alzheimer’s patients. The bapi Phase III results speak with a resounding “No”. We are still awaiting Phase III results from Eli Lilly’s solanezumab, but the current prognosis [...]

A research team at Washington University School of Medicine just published the results of a study that looked at a number of cognitive changes and biomarkers that can be used to predict the risk of Alzheimer’s Disease long before symptoms appear – in some cases up to 20 years before symptom onset. The study, published [...]

Cambridge Cognition announced the general release of a new iPad application for the detection of early memory impairment that is common in Alzheimer’s disease and other forms of dementia. As we reported last September, the iPad application (named CANTABmobile) is based on the Cantab PAL test, a visual working memory test. The CANTABmobile memory test [...]

What is Mild Cognitive Impairment? Mild Cognitive Impairment, or MCI, is an intermediate stage condition between normal cognitive functioning and Alzheimer’s disease or other types of dementia: Signs of MCI include a “change in cognition” — this typically means memory problems, but it can also include planning and reasoning skills that could negatively affect higher [...]